等待开盘 05-11 09:30:00 美东时间
+0.005
+0.16%
Needham analyst Serge Belanger downgrades Esperion Therapeutics (NASDAQ:ESPR) from Buy to Hold.
05-05 03:05
Stocks traded mixed, with Dow down 0.1% but NASDAQ up 1.06%. Chevron reported mixed Q1 results. Esperion, Five9, Atlassian soared while Summit, Crescent, LendingTree fell.
05-02 03:39
US stocks traded higher, with the Nasdaq up 1%. Dow up 0.05%, Nasdaq up 1.13%, S&P 500 up 0.58%. Tech shares jumped 1.6%, energy stocks fell 1.5%.
05-02 02:15
Esperion Therapeutics shares rise premarket after agreeing to a ~$1.1B acquisition by ARCHIMED, offering $3.16 per share plus milestone payments.
05-01 20:27
Esperion Therapeutics (NASDAQ:ESPR) will release its quarterly earnings report ...
03-10 00:01
Esperion (ESPR) shares dip premarket after announcing a $75M deal to buy Corstasis Therapeutics, adding FDA-approved nasal spray Enbumyst.
03-03 21:25
Companies Reporting Before The Bell • Clear Channel Outdoor (NYSE:CCO) is expec...
2025-11-06 19:12
中国新能源汽车产业链正以惊人的速度驶出国门,去年,电动汽车出口首次突破200万辆,锂电池出口高达39.1亿个。 这一亮眼成绩单背后,却暗藏着挑战。 欧盟《新电...
2025-07-11 18:39
Esperion与Hetero USA达成和解协议,Hetero USA同意在2040年4月19日之前不在美国市场销售NEXLETOL的通用版本;关于其他被告的诉讼仍在进行中。公司致力于开发治疗心血管疾病的新型药物,并继续推进其下一代ATP柠檬酸裂解酶抑制剂的研究。 annunci🧒
2025-06-02 12:00